Abstract
1 The effects of age and sex on the disposition of clobazam (CBZ), a 1.5-benzodiazepine derivative, were evaluated in a series of 29 healthy volunteers aged 18 to 72 years, who ingested single 20 mg oral doses. CBZ kinetics were determined from multiple plasma concentrations measured during 7 days after the dose. 2 CBZ was rapidly absorbed, with peak levels reached an average of 1.5 h after dosing (range 0.5--2.5 h). Mean absorption half-life was 19.7 min. Absorption kinetics were not influenced by age of sex. 3 Elimination half-life ranged from 11 to 77 h, and was significantly longer in elderly v young males (48 v 17 h, P less than 0.01). In women, half-life also increased with age, but differences between young and elderly women were less striking (31 v 49 h, P less than 0.05). 4 Volume of distribution (Vd) was influenced by age and sex. Vd became larger with age regardless of sex, and within each age group was larger in women than in men. Total clearance was unrelated to age in women, but declined significantly with age in men (P less than 0.01). 5 The mean free fraction for CBZ in plasma was 11.5% (range 8.6--15.0%), and tended to increase with age, partly due to a significant age-related decline in plasma albumin concentration (r = -0.68, P less than 0.001). Correction of Vd and clearance for individual differences in binding did not alter their relation to age and sex. 6 As in the case of other benzodiazepines biotransformed by oxidative pathways, the capacity for N-demethylation of CBZ declines with age in men, but age has a minimal effect on CBZ clearance in women.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allen M. D., Greenblatt D. J., Harmatz J. S., Shader R. I. Desmethyldiazepam kinetics in the elderly after oral prazepam. Clin Pharmacol Ther. 1980 Aug;28(2):196–202. doi: 10.1038/clpt.1980.150. [DOI] [PubMed] [Google Scholar]
- Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Clobazam: a review of its pharmacological properties and therapeutic use in anxiety. Drugs. 1980 Sep;20(3):161–178. doi: 10.2165/00003495-198020030-00001. [DOI] [PubMed] [Google Scholar]
- Greenblatt D. J., Allen M. D., Harmatz J. S., Shader R. I. Diazepam disposition determinants. Clin Pharmacol Ther. 1980 Mar;27(3):301–312. doi: 10.1038/clpt.1980.40. [DOI] [PubMed] [Google Scholar]
- Greenblatt D. J. Electron-capture GLC determination of clobazam and desmethylclobazam in plasma. J Pharm Sci. 1980 Nov;69(11):1351–1352. doi: 10.1002/jps.2600691131. [DOI] [PubMed] [Google Scholar]
- Greenblatt D. J., Shader R. I. Effects of age and other drugs on benzodiazepine kinetics. Arzneimittelforschung. 1980;30(5A):886–890. [PubMed] [Google Scholar]
- Hanks G. W. Clobazam: pharmacological and therapeutic profile. Br J Clin Pharmacol. 1979;7 (Suppl 1):151S–155S. doi: 10.1111/j.1365-2125.1979.tb04685.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kanto J., Mäenpä M., Mäntylä R., Sellman R., Valovirta E. Effect of age on the pharmacokinetics of diazepam given in conjunction with spinal anesthesia. Anesthesiology. 1979 Aug;51(2):154–159. doi: 10.1097/00000542-197908000-00013. [DOI] [PubMed] [Google Scholar]
- Klotz U., Müller-Seydlitz P. Altered elimination of desmethyldiazepam in the elderly. Br J Clin Pharmacol. 1979 Jan;7(1):119–120. doi: 10.1111/j.1365-2125.1979.tb00908.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Woo E., Greenblatt D. J. Pharmacokinetic and clinical implications of quinidine protein binding. J Pharm Sci. 1979 Apr;68(4):466–470. doi: 10.1002/jps.2600680419. [DOI] [PubMed] [Google Scholar]